Multiple Sclerosis: Pathogenesis, Symptoms, Diagnoses and Cell-Based Therapy
- PMID: 28367411
- PMCID: PMC5241505
- DOI: 10.22074/cellj.2016.4867
Multiple Sclerosis: Pathogenesis, Symptoms, Diagnoses and Cell-Based Therapy
Abstract
Multiple sclerosis (MS) is a chronic inflammatory disease characterized by central nervous system (CNS) lesions that can lead to severe physical or cognitive disability as well as neurological defects. Although the etiology and pathogenesis of MS remains unclear, the present documents illustrate that the cause of MS is multifactorial and include genetic predisposition together with environmental factors such as exposure to infectious agents, vitamin deficiencies, and smoking. These agents are able to trigger a cascade of events in the immune system which lead to neuronal cell death accompanied by nerve demyelination and neuronal dysfunction. Conventional therapies for MS are based on the use of anti-inflammatory and immunomodulatory drugs, but these treatments are not able to stop the destruction of nerve tissue. Thus, other strategies such as stem cell transplantation have been proposed for the treatment of MS. Overall, it is important that neurologists be aware of current information regarding the pathogenesis, etiology, diagnostic criteria, and treatment of MS. Thus, this issue has been discussed according to recent available information.
Keywords: Cell Therapy; Demyelination; Etiology; Multiple Sclerosis.
Figures
Similar articles
-
Stem Cell Therapy for Multiple Sclerosis.Adv Exp Med Biol. 2019;1084:145-174. doi: 10.1007/5584_2018_247. Adv Exp Med Biol. 2019. PMID: 30039439 Review.
-
[New directions of immunocorrection in multiple sclerosis].Zh Nevrol Psikhiatr Im S S Korsakova. 2020;120(2):103-109. doi: 10.17116/jnevro2020120021103. Zh Nevrol Psikhiatr Im S S Korsakova. 2020. PMID: 32307419 Review. Russian.
-
Neuronal injury in chronic CNS inflammation.Best Pract Res Clin Anaesthesiol. 2010 Dec;24(4):551-62. doi: 10.1016/j.bpa.2010.11.001. Epub 2010 Nov 29. Best Pract Res Clin Anaesthesiol. 2010. PMID: 21619866 Review.
-
Progress in the Application of Drugs for the Treatment of Multiple Sclerosis.Front Pharmacol. 2021 Jul 13;12:724718. doi: 10.3389/fphar.2021.724718. eCollection 2021. Front Pharmacol. 2021. PMID: 34326775 Free PMC article. Review.
-
Current multiple sclerosis treatments have improved our understanding of MS autoimmune pathogenesis.Eur J Immunol. 2016 Sep;46(9):2078-90. doi: 10.1002/eji.201646485. Eur J Immunol. 2016. PMID: 27467894 Review.
Cited by
-
Hepatitis B Vaccine and Multiple Sclerosis: Cause or Coincidence.Cureus. 2022 Oct 5;14(10):e29941. doi: 10.7759/cureus.29941. eCollection 2022 Oct. Cureus. 2022. PMID: 36348919 Free PMC article.
-
An Update on the Effects of Vitamin D on the Immune System and Autoimmune Diseases.Int J Mol Sci. 2022 Aug 29;23(17):9784. doi: 10.3390/ijms23179784. Int J Mol Sci. 2022. PMID: 36077185 Free PMC article. Review.
-
Potential Crosstalk between the PACAP/VIP Neuropeptide System and Endoplasmic Reticulum Stress-Relevance to Multiple Sclerosis Pathophysiology.Cells. 2023 Nov 15;12(22):2633. doi: 10.3390/cells12222633. Cells. 2023. PMID: 37998368 Free PMC article. Review.
-
Comparative Profiling of TG2 and Its Effectors in Human Relapsing Remitting and Progressive Multiple Sclerosis.Biomedicines. 2022 May 26;10(6):1241. doi: 10.3390/biomedicines10061241. Biomedicines. 2022. PMID: 35740263 Free PMC article.
-
Impact of Glatiramer Acetate on B Cell-Mediated Pathogenesis of Multiple Sclerosis.CNS Drugs. 2018 Nov;32(11):1039-1051. doi: 10.1007/s40263-018-0567-8. CNS Drugs. 2018. PMID: 30315499 Free PMC article. Review.
References
-
- Compston A, Coles A. Multiple sclerosis. Lancet. 2008;372(9648):1502–1517. - PubMed
-
- Weiner HL. A shift from adaptive to innate immunity: a potential mechanism of disease progression in multiple sclerosis. J Neurol. 2008;255(Suppl 1):3–11. - PubMed
-
- Gadoth N. Multiple sclerosis in children. Brain Dev. 2003;25(4):229–232. - PubMed
-
- Boiko A, Vorobeychicle G, Paty D, Devonshire V, Sondovnick D. University of British Columbia MS Clinic Neurologists.Early onset multiple sclerosis: a long longitudinal study. Neurology. 2002;59(7):1006–1010. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical